Estudo do perfil genético de pacientes com Neoplasias Mieloproliferativas (NMP) cromossomo Filadélfia negativo

Estudo do perfil genético de pacientes com Neoplasias Mieloproliferativas (NMP) cromossomo Filadélfia negativo

As neoplasias mieloproliferativas (NMPs) Filadelfia negativo como a policitemia vera (PV), trombocitemia essencial (TE) e mielofibrose primária (MFP) são desordens clonais da célula tronco hematopoiética caracterizadas pela produção excessiva de células mielóides diferenciadas. Este fenômeno ocorre...

Full description

Bibliographic Details
Main Author:	Marchiani, Mariana
Other Authors:	Bendit, Israel
Format:	Others
Language:	pt
Published:	Biblioteca Digitais de Teses e Dissertações da USP 2016
Subjects:	Calreticulin Calreticulina Janus kinase 2 Janus quinase 2 Mielofibrose primária Myeloproliferative disorders Policitemia vera Polycythemia vera Primary myelofibrosis Thrombocythemia essential Transtornos mieloproliferativos Trombocitemia essencial
Online Access:	http://www.teses.usp.br/teses/disponiveis/5/5167/tde-02052016-124952/

Similar Items

Estudo do perfil genético de pacientes com Neoplasias Mieloproliferativas (NMP) cromossomo Filadélfia negativo
by: Mariana Marchiani
Published: (2016)

Neoplasias mieloproliferativas: revisão dos critérios diagnósticos e dos aspectos clínicos Myeloproliferative neoplasms: a review of diagnostic criteria and clinical aspects
by: Maria de Lourdes L. F. Chauffaille
Published: (2010-01-01)

Estudo comparativo entre diferentes metodologias na detecção da mutação JAK2V617F em Neoplasias Mieloproliferativas Crônicas BCR-ABL1 negativo
by: Alline Didone
Published: (2015)

Estudo comparativo entre diferentes metodologias na detecção da mutação JAK2V617F em Neoplasias Mieloproliferativas Crônicas BCR-ABL1 negativo
by: Didone, Alline
Published: (2015)

Impacto da análise molecular da mutação JAK2V617F no diagnóstico de neoplasias mieloproliferativas crônicas de acordo com os critérios da OMS 2016
by: Pedrazzani, Fabiane Spagnol
Published: (2017)

Impacto da análise molecular da mutação JAK2V617F no diagnóstico de neoplasias mieloproliferativas crônicas de acordo com os critérios da OMS 2016
by: Pedrazzani, Fabiane Spagnol
Published: (2017)

Impacto da análise molecular da mutação JAK2V617F no diagnóstico de neoplasias mieloproliferativas crônicas de acordo com os critérios da OMS 2016
by: Pedrazzani, Fabiane Spagnol
Published: (2017)

A mutação JAK2 V617F e as síndromes mieloproliferativas JAK2 V617F mutation and the myeloproliferative disorders
by: Bárbara C. R. Monte-Mór, et al.
Published: (2008-01-01)

Janus kinase inhibitors: jackpot or potluck?
by: Pavithran Keechilat, et al.
Published: (2012-06-01)

Molecular biology of Philadelphia-negative myeloproliferative neoplasms
by: Paulo Vidal Campregher, et al.
Published: (2012-01-01)

Clinical and molecular profile of a Brazilian cohort of patients with classical BCR-ABL1-negative myeloproliferative neoplasms
by: Moysés Antonio Porto-Soares, et al.
Published: (2020-07-01)

Synergic Crosstalk between Inflammation, Oxidative Stress, and Genomic Alterations in BCR–ABL-Negative Myeloproliferative Neoplasm
by: Alessandro Allegra, et al.
Published: (2020-10-01)

Depressive symptoms and myeloproliferative neoplasms: Understanding the confounding factor in a complex condition
by: Leslie Padrnos, et al.
Published: (2020-11-01)

Disease-Specific Derangement of Circulating Endocannabinoids and <i>N</i>-Acylethanolamines in Myeloproliferative Neoplasms
by: Dorian Forte, et al.
Published: (2020-05-01)

Impact of Myeloproliferative neoplasms on patients’ employment status and work productivity in the United States: results from the living with MPNs survey
by: Jingbo Yu, et al.
Published: (2018-04-01)

A systematic review and meta-analysis of the prevalence of thrombosis and bleeding at diagnosis of Philadelphia-negative myeloproliferative neoplasms
by: Tarinee Rungjirajittranon, et al.
Published: (2019-02-01)

The Power of Extracellular Vesicles in Myeloproliferative Neoplasms: “Crafting” a Microenvironment That Matters
by: Lucia Catani, et al.
Published: (2021-09-01)

Risks of Solid and Lymphoid Malignancies in Patients with Myeloproliferative Neoplasms: Clinical Implications
by: Mette Brabrand, et al.
Published: (2020-10-01)

Systematization of analytical studies of polycythemia vera, essential thrombocythemia and primary myelofibrosis, and a meta-analysis of the frequency of JAK2, CALR and MPL mutations: 2000–2018
by: Mónica Mejía-Ochoa, et al.
Published: (2019-06-01)

Myeloproliferative neoplasms (MPNs) – Part 2: A nursing guide to managing the symptom burden of MPNs
by: Sabrina Fowlkes, et al.
Published: (2018-11-01)

Comparison of molecular genetic methods of detection of mutations in the CALR gene in myeloproliferative disorders
by: L. A. Kesaeva, et al.
Published: (2019-07-01)

Recent insights regarding the molecular basis of myeloproliferative neoplasms
by: Mi-Ae Jang, et al.
Published: (2020-01-01)

Liquid Biopsy and Potential Liquid Biopsy-Based Biomarkers in Philadelphia-Negative Classical Myeloproliferative Neoplasms: A Systematic Review
by: Mihnea-Alexandru Găman, et al.
Published: (2021-07-01)

Impact of Mutational Profile on the Management of Myeloproliferative Neoplasms: A Short Review of the Emerging Data
by: Loscocco GG, et al.
Published: (2020-12-01)

Myeloproliferative blood cancers as a human neuroinflammation model for development of Alzheimer’s disease: evidences and perspectives
by: Hans C. Hasselbalch, et al.
Published: (2020-08-01)

Next Generation Sequencing in MPNs. Lessons from the Past and Prospects for Use as Predictors of Prognosis and Treatment Responses
by: Vibe Skov
Published: (2020-08-01)

Incidence of myeloproliferative neoplasms in Calgary, Alberta, Canada
by: Jonathan Heppner, et al.
Published: (2019-05-01)

WT1 Gene Overexpression in Differential Diagnosis of Ph-negative Myeloproliferative Disorders
by: EG Lomaia, et al.
Published: (2019-05-01)

The 2020 revision of the guidelines for the management of myeloproliferative neoplasms
by: Sung-Yong Kim, et al.
Published: (2021-01-01)

Philadelphia-negative chronic myeloproliferative neoplasms
by: Rosane Isabel Bittencourt, et al.
Published: (2012-01-01)

Clinical and Laboratory Features of JAK2 V617F, CALR, and MPL Mutations in Malaysian Patients with Classical Myeloproliferative Neoplasm (MPN)
by: Razan Hayati Zulkeflee, et al.
Published: (2021-07-01)

The Role of Inflammation and Inflammasome in Myeloproliferative Disease
by: Lucia Longhitano, et al.
Published: (2020-07-01)

Clinical and laboratory presentations of Janus Kinase II-positive patients in Saudi population
by: H Malhan, et al.
Published: (2014-01-01)

JAK2 V617F prevalence in Brazilian patients with polycythemia vera, idiopathic myelofibrosis and essential thrombocythemia
by: Bárbara da Costa Reis Monte-Mór, et al.
Published: (2007-03-01)

Thrombotic and hemorrhagic events in 2016 World Health Organization-defined Philadelphia-negative myeloproliferative neoplasm
by: Ik-Chan Song, et al.
Published: (2021-09-01)

Efeito de SMADs<i/> e de microRNAs na expressão gênica de TGF-β1 e seu papel na angiogênese em pacientes com mielofibrose e trombocitemia essencial
by: Daniela Prudente Teixeira Nunes
Published: (2015)

Efeito de SMADs<i/> e de microRNAs na expressão gênica de TGF-β1 e seu papel na angiogênese em pacientes com mielofibrose e trombocitemia essencial
by: Nunes, Daniela Prudente Teixeira
Published: (2015)

Alterações da expressão de apoptomirs, de genes e proteínas pró- e anti-apoptóticos em Mielofibrose e Trombocitemia Essencial
by: Raquel Tognon-Ribeiro
Published: (2011)

Alterações da expressão de apoptomirs, de genes e proteínas pró- e anti-apoptóticos em Mielofibrose e Trombocitemia Essencial
by: Tognon-Ribeiro, Raquel
Published: (2011)

NK Cells in Myeloproliferative Neoplasms (MPN)
by: Erin Naismith, et al.
Published: (2021-08-01)